APOE interacts with age to modify rate of decline in cognitive and brain changes in Alzheimer's disease
Yu-Ling Chang1, Christine Fennema-Notestine2, Dominic Holland3
1Department of Psychology, National Taiwan University, Taipei, Taiwan.
Objective:
To determine (1) whether age-standardized cognitive declines and brain morphometric change differ between Young-Old patients with Alzheimer's disease (YOAD) and Very-Old patients with Alzheimer's disease (VOAD), and (2) whether the apolipoprotein E (APOE) genotype modifies these neuropsychological and morphometric changes.
Methods:
Baseline and 12-month follow-up neuropsychological and morphometric measures were examined for healthy control subjects and patients with AD. The two AD groups were divided further into subgroups on the basis of the presence of at least one APOE ε4 allele.
Results:
The YOAD group showed more severe deficits and steeper declines in cognition than the VOAD group. Moreover, the presence of an APOE ε4 allele had a more deleterious effect on the YOAD group than the VOAD group on cognition and brain structure both cross-sectionally and longitudinally.
Conclusions:
Results underscore the importance of integrating an individual's age and genetic susceptibility--and their interaction--when examining neuropsychological and neuroimaging changes in the early stages of Alzheimer's disease.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:23Alzheimer Disease ll: Pathophysiology
01:30Cognitive Development During Adulthood
01:22Alzheimer's Disease: Treatment
01:26Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...